Seeking Alpha

Ferro (FOE) completes sale of pharmaceutical business to PLI Holdings for $16.9M in cash and up...

Ferro (FOE) completes sale of pharmaceutical business to PLI Holdings for $16.9M in cash and up to $8M in incentive payments over two years. The company is selling non-core assets as it seeks to pacify skeptical shareholders who believe the company should have accepted what SA contributor Dr. Jacques Saint-Pierre called a "fair" buyout offer last month. 
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)